|ULB Research||Description of the Unit||Projects of the Unit||Composition|
|Collaborations of the Unit||Protected technologies||Publications||Skills|
Faced with a pathogen - whether a virus, a bacterium, a fungus or a physical agent - the body defends itself by mobilising the immune system. In certain cases however, this defence fails and the parasite is able to outwit the immune system response. In other cases, the defence system goes out of control (as in the case of allergies), or leads to undesirable effects (autoimmune diseases, rejection of grafts). An in-depth understanding of the way the immune system functions is thus essential in a large number of fields in the health and public health sectors. For several decades now, the use of vaccines has enabled a significant reduction in the impact of several infectious diseases, with certain diseases even being eradicated. Others remain however resistant, especially those affecting less-developed countries, and there is still a great amount of work needing to be done in this field. The mobilisation of immune responses is also a priority field of research in cancer treatment: gaining a better understanding of the interaction between the immune system and cancer cells is expected to allow the development of strategies helping the organism to better defend itself against the tumour. ULB teams are focusing on clinical research (vaccinology, viral, bacterial and parasitic infections, immuno-deficiencies in early childhood), on regulating immune responses (transplantations, cell therapies, cancer-related immunotherapy), and on innate immunity and inflammation. With the support of Wallonia and the European Union, the ULB has developed a scientific and industrial campus in Charleroi, focused on immunology and cooperating closely with the teaching hospital and other hospitals in its network. With its Centre for Microscopy and Molecular Imaging (CMMI), the campus has at its disposal a unique set of preclinical imaging equipment covering all technologies, from a molecular scale to that of a whole animal, as well as advanced animal housing for mice with ''humanised'' immune systems. This campus, the Biopark Charleroi Brussels South, is in itself an ecosystem where academic research (both fundamental and applied) teams up with major pharmaceutical companies and a large number of highly specialised and very innovative small companies and university spin-offs.